FDA Inspection 1281150 — Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
The FDA completed an inspection of Xiamen Kang Zhongyuan Biotechnology Co., Ltd. on August 15, 2025 in Xiamen. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 15, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xiamen (China)